{"id":1092,"date":"2025-11-20T08:11:00","date_gmt":"2025-11-20T07:11:00","guid":{"rendered":"https:\/\/www.nutrimedia.info\/?post_type=news&#038;p=1092"},"modified":"2025-11-18T16:32:44","modified_gmt":"2025-11-18T15:32:44","slug":"glp-1-and-lifestyle-cardio-gain-watch","status":"publish","type":"news","link":"https:\/\/www.nutrimedia.info\/en\/news\/glp-1-et-mode-de-vie-gain-cardio-demontre\/","title":{"rendered":"When GLP-1 becomes more powerful with lifestyle"},"content":{"rendered":"<p><strong>The data has just been presented at the scientific sessions of the<a href=\"https:\/\/newsroom.heart.org\/news\/healthy-lifestyle-combined-with-newer-diabetes-medications-lowered-cardiovascular-risk\" data-type=\"link\" data-id=\"https:\/\/newsroom.heart.org\/news\/healthy-lifestyle-combined-with-newer-diabetes-medications-lowered-cardiovascular-risk\" target=\"_blank\" rel=\"noreferrer noopener\">\u2019American Heart Association (AHA) 2025<\/a> A large cohort (over 63,000 patients) with type 2 diabetes shows that the use of GLP-1 receptor agonists (GLP-1 RA) <em>and<\/em> the adoption of a set of \u00abhealthy lifestyle\u00bb behaviours is associated with a marked reduction in major cardiovascular events - much more so than medication or lifestyle changes alone. For healthcare professionals, R&amp;D managers and players in the ingredients and nutraceuticals industry, the message is clear: the synergy between treatment and lifestyle is becoming an essential lever.<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Why does the study contrast slightly with what was known about GLP-1 and its receptor agonists?<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>What we knew<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Patients with type 2 diabetes are known to have a high cardiovascular risk.<\/li>\n\n\n\n<li>It has also been proven that <a href=\"https:\/\/www.nutrimedia.info\/en\/news\/glp-1-the-tsunami-sweeping-away-traditional-slimming-diets\/\" data-type=\"news\" data-id=\"547\">GLP-1 agonists <\/a>have a beneficial effect not only on blood sugar levels but also on the cardiovascular profile. <\/li>\n\n\n\n<li>Similarly, lifestyle habits (physical activity, diet, not smoking...) reduce the overall risk.<br><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>What this study adds<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>It quantifies: in this cohort of 63,656 veterans, those taking a GLP-1 RA and adhering to <em>at least six healthy lifestyle habits<\/em> have seen a <strong>~50 % reduction in the risk of a major cardio event<\/strong> compared with those in standard care + \u22643 healthy habits.<\/li>\n\n\n\n<li>Another key figure: membership of <em>8 healthy habits<\/em> was associated with a ~63 % reduction in risk. <\/li>\n\n\n\n<li>The message is clear: medication <em>increases<\/em> when accompanied by behavioural changes.<br><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Points to watch<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>This is a <strong>observational study<\/strong>, This non-randomised study has not yet been published as a peer-review manuscript. <\/li>\n\n\n\n<li>The population is overwhelmingly male (\u224894 %), with 82 % white, and they are veterans: this limits generalisation. <\/li>\n\n\n\n<li>The \u00ab6 or more healthy habits\u00bb scheme needs to be developed in more detail before it can be translated into recommendations.<br><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>What \u201chealthy habits\u201d means in this study<\/strong><\/h2>\n\n\n\n<p>In the analysis, the lifestyle habits considered included :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>healthy eating,<\/li>\n\n\n\n<li>sufficient physical activity,<\/li>\n\n\n\n<li>non-smoking,<\/li>\n\n\n\n<li>restful sleep,<\/li>\n\n\n\n<li>no or moderate alcohol consumption,<\/li>\n\n\n\n<li>stress management,<\/li>\n\n\n\n<li>social connection and support,<\/li>\n\n\n\n<li>absence of opioid dependence. <\/li>\n<\/ul>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><strong>In other words, a holistic approach (and not just one based on diet or exercise) is essential to this data.<\/strong><\/p>\n<\/blockquote>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"631\" src=\"https:\/\/www.nutrimedia.info\/wp-content\/uploads\/2025\/11\/goffredo-crollalanza-ZPak5_1BGDA-unsplash-e1763132859956-1024x631.jpg\" alt=\"When GLP-1 becomes more powerful with lifestyle\" class=\"wp-image-1093\" srcset=\"https:\/\/www.nutrimedia.info\/wp-content\/uploads\/2025\/11\/goffredo-crollalanza-ZPak5_1BGDA-unsplash-e1763132859956-980x551.jpg 980w, https:\/\/www.nutrimedia.info\/wp-content\/uploads\/2025\/11\/goffredo-crollalanza-ZPak5_1BGDA-unsplash-e1763132859956-480x270.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Implications for the ingredients industry &amp; B2B health<\/strong><\/h2>\n\n\n\n<p>Here are a few angles to consider.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>1. Product positioning<\/strong><\/h3>\n\n\n\n<p>If you are working on ingredients or formulations targeting metabolism, weight management or cardiometabolic health: this type of data reinforces the need to include \u00ablifestyle + pharmacology\u00bb or \u00abcomplementary to drug treatment\u00bb claims. On the other hand: don't claim that your ingredient alone replaces medication (that would be unrealistic). Hypothesis to be validated: are your targets (R&amp;D, medical affairs, innovation managers) aware of this synergy?<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>2. Content strategy \/ healthcare education<\/strong><\/h3>\n\n\n\n<p>Communicating on \u00abtreatment + healthy lifestyle = better reduction in cardio risk\u00bb can open up new formats: webinars, infographics, workshops for decision-makers (R&amp;D, KAM, prescribers). The \u201coptimisation of the patient\/production trajectory\u201d angle becomes relevant. A sceptical investor might say, \u201cYes, but can these habits be sold as a service or an ingredient?\u201d \u2192 Need to show how the product really fits into a care + lifestyle pathway.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>3. Business model \/ distribution<\/strong><\/h3>\n\n\n\n<p>The \u201cingredient + lifestyle service\u201d idea could be explored: for example, a premium ingredient for formulation + a programme for digital monitoring of habits (activity, sleep, etc.). Is this a viable channel? You sell to B2B brands: can they add a service component to their offerings? Counter-argument: Food brands may not want to get involved in prescribing treatments or in the medical interface. You need to clearly define the boundary between \u201cingredient\u201d and \u201cmedicine\u201d.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>4. Reality on the ground<\/strong><\/h3>\n\n\n\n<p>Think about the figures: 63,000+ subjects, but a very specific population (veterans). The ROI for a B2B player must take into account the variability of the actual population (male\/female mix, ethnicities, comorbidities). Also: monitor the move towards peer-review publication, because without this the message remains \u201cpreliminary\u201d.<br><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Conclusion<\/strong><\/h2>\n\n\n\n<p>This study shows that for patients with type 2 diabetes, <strong>the \u00abmodern drugs (GLP-1 RA) + multiple lifestyle changes\u00bb combination\u00bb<\/strong> generates a substantial reduction in cardiovascular events. For a professional in the ingredients\/health sector: this is a strong signal: your innovations are no longer just \u201cnutrient vs disease\u201d but \u201cnutrient + active life path\u201d.<br>All that remains is to translate this concept into a clear, validated and credible value proposition.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>FAQ - Anti-diabetic drugs and lifestyle: the winning duo for the heart<\/strong><\/h2>\n\n\n\n<p><strong>Q1. What is the main conclusion of the study presented at AHA 2025?<br><\/strong> In people with type 2 diabetes, the combination of treatment with GLP-1 receptor agonists and the adoption of at least six healthy lifestyle habits reduces by approximately <strong>50 % the risk of major cardiovascular events<\/strong> compared with those who had neither treatment nor a healthy lifestyle.<br><\/p>\n\n\n\n<p><strong>Q2. Does this mean that GLP-1 drugs are ineffective without lifestyle changes?<br><\/strong> No. GLP-1 receptor agonists already reduce cardiovascular risk by approximately <strong>20 %<\/strong> when used alone.<br>But their <strong>double efficiency<\/strong> when combined with a number of healthy lifestyle habits.<br><\/p>\n\n\n\n<p><strong>Q3. What are the limitations of this study?<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>It's a <strong>observational study<\/strong>, So it shows correlation, not causation.<\/li>\n\n\n\n<li>The population is very specific: <strong>American veterans, mostly white men (\u2248 94 %)<\/strong>.<\/li>\n\n\n\n<li>The results come from a <strong>conference presentations<\/strong>, not yet published in a peer-reviewed scientific journal.<br>These factors limit the scope of our conclusions.<br><\/li>\n<\/ul>\n\n\n\n<p><strong>Q4. What should those involved in health or nutritional ingredients remember?<br><\/strong> This study shows that therapeutic efficacy is now dependent on a <strong>integrated \u201cmedication + lifestyle\u201d approach\u201d<\/strong>.<br>Ingredients, clinical nutrition and nutraceutical companies can use this trend to position their products as <strong>additional<\/strong> and not as substitutes.<br>The key: scientific credibility, regulatory clarity and consistency with public health messages.<\/p>","protected":false},"template":"","meta":{"_acf_changed":true,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false},"class_list":["post-1092","news","type-news","status-publish","hentry"],"acf":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.nutrimedia.info\/en\/wp-json\/wp\/v2\/news\/1092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nutrimedia.info\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.nutrimedia.info\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/www.nutrimedia.info\/en\/wp-json\/wp\/v2\/media?parent=1092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}